LFG
STAB

LifePlan Financial Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

LifePlan Financial Group’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-100
Closed -$3K – 256
2013
Q3 		$3K Hold
100
– – ﹤0.01% 186
2013
Q2 		$3K Buy
+100
New +$3.44K ﹤0.01% 163

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LifePlan Financial Group's STAB Position: Q4 2013 in Review

LifePlan Financial Group sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2013, closing a stake of 100 shares — an estimated $3K sold.

LifePlan Financial Group first reported a position in STAB in Q2 2013 and held it in 2 quarters. The position peaked at $3K in Q3 2013. 39 funds tracked by Wall St. Rank hold STAB as of Q4 2013.

  • LifePlan Financial Group reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • LifePlan Financial Group sold 100 Statera Biopharma, Inc. Common Stock shares in Q4 2013, an estimated $3K.
  • LifePlan Financial Group first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 2 quarters.
  • LifePlan Financial Group's Statera Biopharma, Inc. Common Stock position peaked at $3K in Q3 2013.
  • 39 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2013.

Based on LifePlan Financial Group's 13F filing for Q4 2013, filed 3 Feb 2014.